|
US4486414A
(en)
|
1983-03-21 |
1984-12-04 |
Arizona Board Of Reagents |
Dolastatins A and B cell growth inhibitory substances
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
FR2613935B1
(fr)
|
1987-04-15 |
1989-12-01 |
Roussel Uclaf |
Association renfermant a titre de principes actifs, un analgesique central et la forskoline
|
|
US4816444A
(en)
|
1987-07-10 |
1989-03-28 |
Arizona Board Of Regents, Arizona State University |
Cell growth inhibitory substance
|
|
US5076973A
(en)
|
1988-10-24 |
1991-12-31 |
Arizona Board Of Regents |
Synthesis of dolastatin 3
|
|
US4978744A
(en)
|
1989-01-27 |
1990-12-18 |
Arizona Board Of Regents |
Synthesis of dolastatin 10
|
|
US4986988A
(en)
|
1989-05-18 |
1991-01-22 |
Arizona Board Of Regents |
Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13
|
|
US5138036A
(en)
|
1989-11-13 |
1992-08-11 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Isolation and structural elucidation of the cytostatic cyclodepsipeptide dolastatin 14
|
|
JPH0688488B2
(ja)
|
1990-10-23 |
1994-11-09 |
豊治 藤本 |
ペルチェ電子素子型の可搬式エアコン及び換気性衣服
|
|
DE69232552T2
(de)
|
1991-08-09 |
2002-10-31 |
Teikoku Hormone Mfg. Co., Ltd. |
Tetrapeptide Derivat
|
|
CA2081406C
(en)
|
1991-12-23 |
1997-09-16 |
Chinmoy Bhusan Bose |
Method and apparatus for connected and degraded text recognition
|
|
US5831002A
(en)
|
1992-05-20 |
1998-11-03 |
Basf Aktiengesellschaft |
Antitumor peptides
|
|
RU2116312C1
(ru)
|
1992-05-20 |
1998-07-27 |
Басф Акциенгезельшафт |
Производные пептида или их соли, фармацевтическая композиция
|
|
US5635483A
(en)
|
1992-12-03 |
1997-06-03 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Tumor inhibiting tetrapeptide bearing modified phenethyl amides
|
|
US6034065A
(en)
|
1992-12-03 |
2000-03-07 |
Arizona Board Of Regents |
Elucidation and synthesis of antineoplastic tetrapeptide phenethylamides of dolastatin 10
|
|
JPH06172397A
(ja)
|
1992-12-11 |
1994-06-21 |
Nippon Kayaku Co Ltd |
新規物質ドラスタチンｃ及びその用途
|
|
DE69329425T2
(de)
|
1992-12-16 |
2001-01-18 |
Basf Ag |
Dolastatin analog
|
|
US5410024A
(en)
|
1993-01-21 |
1995-04-25 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide amides
|
|
US5780588A
(en)
|
1993-01-26 |
1998-07-14 |
Arizona Board Of Regents |
Elucidation and synthesis of selected pentapeptides
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
KR100332254B1
(ko)
|
1993-10-01 |
2002-09-27 |
데이꼬꾸 조끼 세이야꾸 가부시키가이샤 |
신규인펩티드유도체
|
|
CA2194907A1
(en)
|
1994-07-13 |
1996-02-01 |
Kouji Matsushima |
Reshaped human antibody against human interleukin-8
|
|
US5504191A
(en)
|
1994-08-01 |
1996-04-02 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide methyl esters
|
|
US5521284A
(en)
|
1994-08-01 |
1996-05-28 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory pentapeptide amides and esters
|
|
US5530097A
(en)
|
1994-08-01 |
1996-06-25 |
Arizona Board Of Regents Acting On Behalf Of Arizona State University |
Human cancer inhibitory peptide amides
|
|
WO1996033212A1
(fr)
|
1995-04-21 |
1996-10-24 |
Teikoku Hormone Mfg. Co., Ltd. |
Nouveaux derives peptidiques
|
|
DE19527575A1
(de)
|
1995-07-28 |
1997-01-30 |
Basf Ag |
Verfahren zur Herstellung von peptidischer Wirkstoffe
|
|
JPH0977791A
(ja)
|
1995-09-08 |
1997-03-25 |
Nippon Kayaku Co Ltd |
ペプチド誘導体及びその用途
|
|
US5816444A
(en)
|
1995-10-23 |
1998-10-06 |
Calico Light Weapon Systems |
Rotor and ratchet assembly
|
|
US5807984A
(en)
|
1995-11-09 |
1998-09-15 |
Basf Aktienegesellschaft |
Oligopeptides, the preparation and use thereof
|
|
US5939527A
(en)
|
1996-07-30 |
1999-08-17 |
Basf Aktiengesellschaft |
Tetrapeptides as antitumor agents
|
|
US5741892A
(en)
|
1996-07-30 |
1998-04-21 |
Basf Aktiengesellschaft |
Pentapeptides as antitumor agents
|
|
DE69832158T2
(de)
|
1997-02-25 |
2006-08-10 |
Arizona Board Of Regents, Tempe |
Isolierung und strukturelle aufklärung der kryostatischen linearen und cyclo-depsipeptide dolastatin 16, dolastatin 17, und dolastatin 18
|
|
US5965537A
(en)
|
1997-03-10 |
1999-10-12 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
|
|
US6103698A
(en)
|
1997-03-13 |
2000-08-15 |
Basf Aktiengesellschaft |
Dolastatin-15 derivatives in combination with taxanes
|
|
US6143721A
(en)
|
1997-07-18 |
2000-11-07 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives
|
|
CA2298639C
(en)
|
1997-09-24 |
2005-07-05 |
Erik J. Flahive |
Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
|
|
US6677436B1
(en)
|
1998-04-03 |
2004-01-13 |
Chugai Seiyaku Kabushiki Kaisha |
Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody
|
|
ES2434961T5
(es)
|
1998-04-20 |
2018-01-18 |
Roche Glycart Ag |
Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo
|
|
US5985837A
(en)
|
1998-07-08 |
1999-11-16 |
Basf Aktiengesellschaft |
Dolastatin 15 derivatives
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
EP1176195B1
(en)
|
1999-04-09 |
2013-05-22 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
|
US6323315B1
(en)
|
1999-09-10 |
2001-11-27 |
Basf Aktiengesellschaft |
Dolastatin peptides
|
|
FR2807767B1
(fr)
|
2000-04-12 |
2005-01-14 |
Lab Francais Du Fractionnement |
Anticorps monoclonaux anti-d
|
|
US7256257B2
(en)
|
2001-04-30 |
2007-08-14 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US6737409B2
(en)
|
2001-07-19 |
2004-05-18 |
Hoffmann-La Roche Inc. |
Dolastatin 10 derivatives
|
|
SI1545613T1
(sl)
|
2002-07-31 |
2011-11-30 |
Seattle Genetics Inc |
Avristatinski konjugati in njihova uporaba za zdravljenje raka avtoimunske bolezni ali infekcijskebolezni
|
|
JP2006524039A
(ja)
|
2003-01-09 |
2006-10-26 |
マクロジェニクス，インコーポレーテッド |
変異型Ｆｃ領域を含む抗体の同定および作製ならびにその利用法
|
|
US8388955B2
(en)
|
2003-03-03 |
2013-03-05 |
Xencor, Inc. |
Fc variants
|
|
US7498298B2
(en)
|
2003-11-06 |
2009-03-03 |
Seattle Genetics, Inc. |
Monomethylvaline compounds capable of conjugation to ligands
|
|
DE10359795A1
(de)
|
2003-12-19 |
2005-07-21 |
Bayer Technology Services Gmbh |
Strangverdampfervorrichtung
|
|
WO2006132670A2
(en)
|
2004-11-12 |
2006-12-14 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the n terminus
|
|
EP1817341A2
(en)
|
2004-11-29 |
2007-08-15 |
Seattle Genetics, Inc. |
Engineered antibodies and immunoconjugates
|
|
JP2008523002A
(ja)
|
2004-12-13 |
2008-07-03 |
エフ．ホフマン−ラ ロシュ アーゲー |
少なくとも１つのドラスタチン１０誘導体を含有する新規な医薬組成物
|
|
JP5171621B2
(ja)
|
2005-07-07 |
2013-03-27 |
シアトル ジェネティックス， インコーポレイテッド |
フェニルアラニン側鎖修飾をｃ末端に有するモノメチルバリン化合物
|
|
KR101638490B1
(ko)
|
2008-08-05 |
2016-07-11 |
도레이 카부시키가이샤 |
암의 치료 및 예방용 의약 조성물
|
|
AU2010270979B2
(en)
|
2009-06-22 |
2015-04-23 |
Medimmune, Llc |
Engineered Fc regions for site-specific conjugation
|
|
SG178925A1
(en)
|
2009-09-22 |
2012-04-27 |
Volker Sandig |
Process for producing molecules containing specialized glycan structures
|
|
MX340015B
(es)
|
2010-02-04 |
2016-06-22 |
Toray Industries |
Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
|
|
HUE025678T2
(en)
|
2010-02-04 |
2016-04-28 |
Toray Industries |
A pharmaceutical composition for the treatment and / or prevention of cancer
|
|
RU2598258C2
(ru)
|
2010-02-04 |
2016-09-20 |
Торэй Индастриз, Инк. |
Фармацевтическая композиция для лечения и/или профилактики рака
|
|
KR101842893B1
(ko)
|
2010-02-04 |
2018-03-28 |
도레이 카부시키가이샤 |
암의 치료 및/또는 예방용 의약 조성물
|
|
BR112012018943A8
(pt)
|
2010-02-04 |
2017-12-19 |
Toray Industries |
medicamento e método para o tratamento e/ou prevenção de um câncer
|
|
MX342291B
(es)
|
2010-02-04 |
2016-09-23 |
Toray Industries |
Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
|
|
BR112012024489A2
(pt)
|
2010-03-29 |
2016-05-31 |
Zymeworks Inc |
anticorpos com função efetora suprimida ou aumentada
|
|
CN103200950B
(zh)
|
2010-06-10 |
2016-03-16 |
西雅图基因公司 |
新颖的耳他汀衍生物及其用途
|
|
US9029406B2
(en)
|
2011-03-16 |
2015-05-12 |
Seattle Genetics, Inc |
N-carboxyalkylauristatins and use thereof
|
|
KR102023496B1
(ko)
|
2011-04-21 |
2019-09-20 |
시애틀 지네틱스, 인크. |
신규 결합제-약물 콘주게이트 (adc) 및 그의 용도
|
|
US9175041B2
(en)
|
2011-04-25 |
2015-11-03 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Crystal structures of dolastatin 16, dolamethylleuine and dolaphenvaline, and methods for preparing dolamethylleuine and dolaphenvaline
|
|
KR20140037105A
(ko)
|
2011-05-27 |
2014-03-26 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
|
|
KR102356286B1
(ko)
|
2011-05-27 |
2022-02-08 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
|
|
US9181348B2
(en)
|
2011-08-04 |
2015-11-10 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prophylaxis of cancer
|
|
JP6070191B2
(ja)
|
2011-08-04 |
2017-02-01 |
東レ株式会社 |
癌の治療及び／又は予防用医薬組成物
|
|
RU2595400C2
(ru)
|
2011-08-04 |
2016-08-27 |
Торэй Индастриз, Инк. |
Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли
|
|
PT2740794T
(pt)
|
2011-08-04 |
2018-06-14 |
Toray Industries |
Composição farmacêutica para o tratamento e/ou profilaxia de cancro
|
|
KR102041832B1
(ko)
|
2011-08-04 |
2019-11-08 |
도레이 카부시키가이샤 |
췌장암의 치료 및/또는 예방용 의약 조성물
|
|
PT2740793T
(pt)
|
2011-08-04 |
2018-02-23 |
Toray Industries |
Composição de fármacos para o tratamento e/ou a prevenção de cancro
|
|
CA2848520C
(en)
|
2011-09-29 |
2019-11-26 |
Seattle Genetics, Inc. |
Intact mass determination of protein conjugated agent compounds
|
|
HUE044611T2
(hu)
|
2012-02-21 |
2019-11-28 |
Toray Industries |
Gyógyászati készítmény rák kezelésére
|
|
BR112014021103A2
(pt)
|
2012-02-21 |
2019-10-15 |
Toray Industries, Inc |
Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
|
|
PT2818483T
(pt)
|
2012-02-21 |
2017-10-09 |
Toray Industries |
Composição medicinal para tratamento e/ou prevenção de cancro
|
|
US9260513B2
(en)
|
2012-02-21 |
2016-02-16 |
Toray Industries, Inc. |
Pharmaceutical composition for treatment and/or prevention of cancer
|
|
PT2832366T
(pt)
|
2012-03-30 |
2018-01-25 |
Toray Industries |
Composição farmacêutica para o tratamento e/ou a prevenção de cancro de vesícula biliar
|
|
KR102155531B1
(ko)
|
2012-03-30 |
2020-09-15 |
도레이 카부시키가이샤 |
간암의 치료 및/또는 예방용 의약 조성물
|
|
KR102557309B1
(ko)
|
2012-05-15 |
2023-07-20 |
씨젠 인크. |
자가-안정화 링커 접합체
|
|
CN112587671A
(zh)
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
|
AU2013318779B2
(en)
|
2012-09-20 |
2016-07-28 |
Celltrion, Inc. |
Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same
|
|
FR3005051A1
(fr)
|
2013-04-25 |
2014-10-31 |
Pf Medicament |
Derives de la dolastatine 10 et d'auristatines
|
|
ES2704909T3
(es)
|
2013-08-09 |
2019-03-20 |
Toray Industries |
Composición farmacéutica para el tratamiento y/o la prevención del cáncer
|
|
ES2826398T3
(es)
|
2013-10-15 |
2021-05-18 |
Seagen Inc |
Enlazadores-fármacos pegilados para una mejor farmacocinética de los conjugados ligando-fármaco
|
|
JP6701077B2
(ja)
|
2013-12-19 |
2020-05-27 |
シアトル ジェネティックス， インコーポレイテッド |
標的化薬物結合体と使用するためのメチレンカルバメートリンカー
|
|
JP2017510548A
(ja)
*
|
2014-01-29 |
2017-04-13 |
シャンハイ ヘンルイ ファーマスーティカル カンパニー リミテッドＳｈａｎｇｈａｉ Ｈｅｎｇｒｕｉ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． |
リガンド‐細胞傷害性薬物抱合体、その製造方法、およびその用途
|
|
SG10202001468UA
(en)
|
2014-02-17 |
2020-04-29 |
Seattle Genetics Inc |
Hydrophilic antibody-drug conjugates
|
|
CN106279352B
(zh)
|
2015-05-29 |
2020-05-22 |
上海新理念生物医药科技有限公司 |
海兔毒素10的衍生物及其应用
|
|
KR20180134351A
(ko)
|
2016-03-25 |
2018-12-18 |
시애틀 지네틱스, 인크. |
페길화된 약물-링커 및 그의 중간체의 제조를 위한 공정
|
|
ES2948846T3
(es)
|
2016-03-29 |
2023-09-20 |
Toray Industries |
Derivado peptídico y uso del mismo
|
|
MX2019001302A
(es)
|
2016-08-09 |
2019-06-12 |
Seattle Genetics Inc |
Conjugados de farmaco con enlazadores autoestabilizantes que tienen propiedades fisioquimicas mejoradas.
|
|
KR20240005247A
(ko)
*
|
2016-10-28 |
2024-01-11 |
도레이 카부시키가이샤 |
암의 치료 및/또는 예방용 의약 조성물
|
|
JP7244987B2
(ja)
|
2016-12-14 |
2023-03-23 |
シージェン インコーポレイテッド |
多剤抗体薬物コンジュゲート
|
|
JP7337698B2
(ja)
|
2017-02-28 |
2023-09-04 |
シージェン インコーポレイテッド |
コンジュゲート化のためのシステイン突然変異抗体
|
|
CN111989339A
(zh)
|
2018-02-20 |
2020-11-24 |
西雅图基因公司 |
疏水性奥瑞他汀f化合物及其缀合物
|
|
CN109796522B
(zh)
|
2019-02-18 |
2021-09-21 |
清远中大创新药物研究中心 |
海兔毒素10环肽衍生物及其制备方法和应用
|
|
EP4051691B1
(en)
|
2019-10-28 |
2025-02-12 |
Ariel Scientific Innovations Ltd. |
Dolastatin 10 analog
|
|
IL296277A
(en)
|
2020-03-09 |
2022-11-01 |
Sigma Aldrich Co Llc |
Efficient preparation of dolstatin and oristatin analogs via a common intermediate
|